Zepp Health (ZEPP) Receivables - Other (2016 - 2026)

Zepp Health (ZEPP) has reported Receivables - Other for 11 consecutive years, with $6.2 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables - Other rose 138.71% year-over-year to $6.2 billion; the TTM figure through Mar 2026 stood at $6.2 billion (up 138.71% YoY), while the FY2025 annual figure was $6.7 billion, up 121591.07% from the prior year.
• Receivables - Other declined to $6.2 billion in Q1 2026 per ZEPP's latest filing, from $6.7 billion in the prior quarter.
• Across five years, Receivables - Other topped out at $86.4 billion in Q2 2022 and bottomed at $2.7 million in Q4 2024.
• Historically, Receivables - Other has averaged $15.5 billion across 5 years, with a median of $6.2 billion in 2026.
• Annual changes were most pronounced in 2024 — Receivables - Other tumbled 99.97% — and 2025, when it surged 250181.64%.
• Zepp Health's Receivables - Other stood at $6.3 million in 2022, then soared by 134161.83% to $8.5 billion in 2023, then sank by 99.97% to $2.7 million in 2024, then soared by 250181.64% to $6.7 billion in 2025, then retreated by 7.56% to $6.2 billion in 2026.
• Business Quant data shows ZEPP's Receivables - Other at $6.2 billion in Q1 2026, $6.7 billion in Q4 2025, and $4.4 billion in Q3 2025.